We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nanotechnology Yields 5,000-Year-Old Red Blood Cells from Glacier Mummy

By LabMedica International staff writers
Posted on 16 May 2012
Print article
Using nanotechnology, Italian and German researchers have succeeded in locating red blood cells in the wounds a 5,000-year-old iceman mummy.

Samples from a 5,000-year-old mummy’s stomach and intestines have allowed scientists to reconstruct his very last meal, and his DNA has been decoded. The conditions surrounding his violent death appear to have been clarified. However, what had, at least up to now, eluded the scientists, was finding any traces of blood in Ötzi, the 5,000-year-old glacier mummy.

Examination of his aorta had yielded no results. Yet recently, a team of scientists from Italy and Germany, employing nanotechnology, succeeded in locating red blood cells in Ötzi’s wounds, thereby discovering the oldest traces of blood to have been found anywhere in the world.

“Up to now there had been uncertainty about how long blood could survive--let alone what human blood cells from the Chalcolithic period, the Copper Stone Age, might look like,” Dr. Albert Zink, head of the Institute for Mummies and the Iceman at the European Academy, Bozen-Bolzano (EURAC), explained the beginning of the study that he conducted with Drs. Marek Janko and Robert Stark, materials scientists at the Center of Smart Interfaces at Darmstadt Technical University (Germany). Even in the latest forensic technologye it has so far been almost impossible to determine how long a trace of blood had been present at a crime scene. Scientists Drs. Albert Zink, Marek Janko, and Robert Stark are assured that the nanotechnologic technology that they utilized out on Ötzi’s blood to analyze the microstructure of blood cells and miniscule blood clots might possibly lead to a break-through in this field.

The investigators used an atomic force microscope to examine thin tissue sections from the wound where the arrow entered Ötzi’s back and from the laceration on his right hand. This nanotechnology instrument scans the surface of the tissue sections using a very fine probe. As the probe moves over the surface, sensors measure every miniscule deflection of the probe, point by point and line by line, building up a three-dimensional (3D) image of the surface. What emerged was an image of red blood cells with the classic “doughnut shape,” precisely as is found in healthy people today.

“To be absolutely sure that we were not dealing with pollen, bacteria, or even a negative imprint of a blood cell, but indeed with actual blood cells, we used a second analytical method, the so-called Raman spectroscopy method,” reported Drs. Janko and Stark, who, with Dr. Zink, are also members of the Center for NanoSciences (Munich, Germany). In Raman spectroscopy, the tissue sample is lit by a laser beam and analysis of the spectrum of the scattered light allows the user to identify various molecules. According to the scientists, the images resulting from this process corresponded to present-day samples of human blood.
While examining the wound at the point where the arrow entered the body, scientists also identified fibrin, a protein involved in the clotting of blood. “Because fibrin is present in fresh wounds and then degrades, the theory that Ötzi died some days after he had been injured by the arrow, as had once been mooted, can no longer be upheld,” explained Dr. Albert Zink.

The scientists published their research findings online before print May 2, 2012, in the Journal of the Royal Society Interface.

Related Links:
Darmstadt Technical University



Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Collection Container
Urine Monovette
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: SCOPE IO has shown promise in predicting immunotherapy response in rare cancer patients (Photo courtesy of Lunit)

AI-Powered Whole-Slide Image Analyzer Predicts Immunotherapy Response for Rare Cancer Patients

Immunotherapy, especially immune checkpoint inhibitors like pembrolizumab, has become a groundbreaking treatment for cancer patients. However, not all patients respond the same way to this therapy, and... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.